AMPA receptor positive allosteric modulator

From WikiMD's Medical Encyclopedia

Revision as of 01:31, 18 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

AMPA receptor positive allosteric modulator

Chemical structure of CX-516
Chemical structure of Tulrampator

An AMPA receptor positive allosteric modulator is a type of compound that enhances the activity of the AMPA receptor, a subtype of the ionotropic glutamate receptors in the central nervous system. These modulators bind to the receptor at a site distinct from the glutamate binding site, leading to an increase in the receptor's response to glutamate.

Mechanism of Action

AMPA receptor positive allosteric modulators work by binding to the allosteric site on the AMPA receptor. This binding induces a conformational change in the receptor, which increases its affinity for glutamate and/or prolongs the open state of the ion channel. As a result, there is an increase in the flow of sodium ions (Na_) and calcium ions (Ca__) into the neuron, leading to enhanced synaptic transmission and neuroplasticity.

Pharmacological Effects

The primary effect of AMPA receptor positive allosteric modulators is the potentiation of excitatory synaptic transmission. This can lead to improved cognitive function, enhanced memory, and increased alertness. These compounds are being investigated for their potential therapeutic effects in conditions such as Alzheimer's disease, schizophrenia, and depression.

Examples

Several compounds have been identified as AMPA receptor positive allosteric modulators, including:

  • CX-516: Also known as Ampalex, CX-516 is one of the first AMPA receptor modulators to be studied for its cognitive-enhancing effects.
  • Tulrampator: A more recent compound, Tulrampator has shown promise in preclinical studies for its potential to improve cognitive function.

Research and Development

Research into AMPA receptor positive allosteric modulators is ongoing, with a focus on developing compounds with improved efficacy and safety profiles. Challenges include minimizing potential side effects such as excitotoxicity and seizures, which can result from excessive activation of glutamate receptors.

Related pages

Gallery

  • Chemical structure of CX-516
    Chemical structure of CX-516
  • Chemical structure of Tulrampator
    Chemical structure of Tulrampator

AMPA_receptor_positive_allosteric_modulator

  • CX-516 2D skeletal structure
    CX-516 2D skeletal structure
  • Tulrampator skeletal structure
    Tulrampator skeletal structure
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=AMPA_receptor_positive_allosteric_modulator&oldid=6311842"